USFDA approval sends this multibagger pharma stock to 52-week high 0 27.08.2024 12:31 Business Standard Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
